Top brokers name 3 ASX shares to buy next week

Brokers gave the thumbs up to these ASX shares last week. Here's why they are bullish on them…

| More on:
Broker written in white with a man drawing a yellow underline.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was another busy week for Australia's top brokers. This led to the release of a large number of broker notes.

Three ASX broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

Liontown Resources Ltd (ASX: LTR)

According to a note out of Bell Potter, its analysts have retained their speculative buy rating and $3.35 price target on this lithium miner's shares. Bell Potter was pleased with news that the company is pushing ahead with its direct shipping ore (DSO) plans. The broker notes that this will generate revenue before full production commences next year. How much? Well, based on current prices (SC6 ~US$3,500/t), Bell Potter suspects that Liontown could generate over $100 million in revenue from its DSO. The Liontown share price was fetching $2.74 at Friday's close.

ResMed Inc. (ASX: RMD)

A note out of Goldman Sachs reveals that its analysts have retained their buy rating on this sleep treatment company's shares with a $38.40 price target. While Goldman was disappointed with ResMed's quarterly update and weaker margins, it remains positive. The broker highlights that in the context of various unprecedented market dynamics, it feels the factors suppressing ResMed's margins are generally understandable and likely to improve. In light of this, the broker thinks the recent weakness could be a buying opportunity. The ResMed share price ended the week at $30.70.

Xero Limited (ASX: XRO)

Analysts at Goldman Sachs have retained their conviction buy rating on this cloud accounting platform provider's shares with an improved price target of $147. According to the note, the broker believes that small business data shows that this side of the economy is holding up better than expected in the current environment. As a result, the broker has lowered its churn assumptions and boosted its revenue and earnings estimates for the coming years. The Xero share price was trading at $122.20 on Friday.

Motley Fool contributor James Mickleboro has positions in Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, ResMed, and Xero. The Motley Fool Australia has positions in and has recommended ResMed and Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in June

The broker is feeling bullish on these names this month. Let's find out why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Bell Potter says this ASX 200 share can rise 25%

Let's see what the broker is saying about this stock.

Read more »

Stethoscope with a piggy bank in the middle.
Broker Notes

Australian health insurance: Does Macquarie prefer Medibank or NIB shares?

Medibank and NIB shares have both surged in 2025. Here’s what Macquarie expects now.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

9 ASX 200 shares just upgraded to strong buy ratings

Brokers have upgraded these shares amid expectations of price growth over the next 12 months.

Read more »

Red sell button on an Apple keyboard.
Broker Notes

Sell alert! Brokers say pull the plug on these 3 ASX 200 shares

Experts say it's time to press the sell button on these ASX 200 shares. Find out why.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

Macquarie forecasts 40% upside for this ASX All Ords stock

Let's see which stock the broker is tipping as a buy.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A smiling woman with a handful of $100 notes, indicating strong dividend payments
Broker Notes

Where to invest $10,000 in ASX 200 shares this month

Brokers think these shares could be top picks for your hard-earned money this month.

Read more »